Plasma levels of nitric oxide metabolites are markedly reduced in normotensive men with electrocardiographically determined left ventricular hypertrophy

Hypertension

Volumn 64, Issue 3, 2014, Pages 516-522

  Kamezaki, Fumihiko ^a   Tsutsui, Masato ^b   Takahashi, Masao ^a   Sonoda, Shinjo ^a   Kubo, Tatsuhiko ^a   Fujino, Yoshihisa ^a   Adachi, Tetsuo ^c   Abe, Haruhiko ^a   Takeuchi, Masaaki ^a   Mayumi, Toshihiko ^a   Otsuji, Yutaka ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Electrocardiography; Hypertrophy; Left ventricular; Nitric oxide; Oxidative stress

Indexed keywords

8 ISOPROSTANE; CHOLESTEROL; EXTRACELLULAR SUPEROXIDE DISMUTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ELECTROCARDIOGRAPHICALLY DETERMINED LEFT VENTRICULAR HYPERTROPHY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; JAPANESE (PEOPLE); LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NITRIC OXIDE BLOOD LEVEL; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; ST SEGMENT DEPRESSION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ELECTROCARDIOGRAPHY; HYPERTROPHY, LEFT VENTRICULAR; NITRIC OXIDE; OXIDATIVE STRESS;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; DINOPROST; ELECTROCARDIOGRAPHY; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; JAPAN; LIPID PEROXIDATION; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; OXIDATIVE STRESS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84907597772     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.03287     Document Type: Article

References (23)

1. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B; LIFE Study Investigators. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004;292: 2343-2349.
2. Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: The LIFE Study. Circulation. 2007;116:700-705.
3. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med. 1983;75(3A):4-11.
4. Nakamura K, Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, Ueshima H; NIPPON DATA90 Research Group. Electrocardiogram screening for left high R-wave predicts cardiovascular death in a Japanese community-based population: NIPPON DATA90. Hypertens Res. 2006;29:353-360.
5. Ishikawa J, Ishikawa S, Kabutoya T, Gotoh T, Kayaba K, Schwartz JE, Pickering TG, Shimada K, Kario K; Jichi Medical School Cohort Study Investigators Group. Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population. Hypertension. 2009;53:28-34.
6. Tsutsui M, Shimokawa H, Otsuji Y, Yanagihara N. Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases. Pharmacol Ther. 2010;128:499-508.
7. Shibata K, Yatera Y, Furuno Y, et al. Spontaneous development of left ventricular hypertrophy and diastolic dysfunction in mice lacking all nitric oxide synthases. Circ J. 2010;74:2681-2692.
8. Nakata S, Tsutsui M, Shimokawa H, Suda O, Morishita T, Shibata K, Yatera Y, Sabanai K, Tanimoto A, Nagasaki M, Tasaki H, Sasaguri Y, Nakashima Y, Otsuji Y, Yanagihara N. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation. 2008;117:2211-2223.
9. Nakashima Y, Toyokawa Y, Tanaka S, Yamashita K, Yashiro A, Tasaki H, Kuroiwa A. Simvastatin increases plasma NO2- And NO3- levels in patients with hypercholesterolemia. Atherosclerosis. 1996;127:43-47.
10. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999;85:753-766.
11. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res. 2000;87:840-844.
12. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47-95.
13. Ellis G, Adatia I, Yazdanpanah M, Makela SK. Nitrite and nitrate analyses: A clinical biochemistry perspective. Clin Biochem. 1998;31:195-220.
14. Wen C, Li M, Fraser T, Wang J, Turner SW, Whitworth JA. L-arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat. Blood Press. 2000;9:298-304.
15. Ohashi Y, Kawashima S, Hirata Ki, Yamashita T, Ishida T, Inoue N, Sakoda T, Kurihara H, Yazaki Y, Yokoyama M. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest. 1998;102:2061-2071.
16. De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G. Angiotensinconverting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol. 2005;516:253-259.
17. Morishita T, Tsutsui M, Shimokawa H, Sabanai K, Tasaki H, Suda O, Nakata S, Tanimoto A, Wang KY, Ueta Y, Sasaguri Y, Nakashima Y, Yanagihara N. Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc Natl Acad Sci U S A. 2005;102:10616-10621.
18. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353:349-361.
19. Calderone A, Thaik CM, Takahashi N, Chang DL, Colucci WS. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest. 1998;101:812-818.
20. Strålin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995;15:2032-2036.
21. Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase: A regulator of nitric oxide bioavailability. Lab Invest. 1996;75:617-636.
22. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995;25:417-423.
23. Ashley EA, Raxwal V, Froelicher V. An evidence-based review of the resting electrocardiogram as a screening technique for heart disease. Prog Cardiovasc Dis. 2001;44:55-67.